Virbac : Half-yearly financial report 2023
Please find attached 2023 Half-yearly financial report of Virbac Attachment Half-Yearly Financial Report_2023
Year: 2023
Spend Matters Names Zip ‘Foremost’ Leader in “Intake Management: Procurement Tech’s Next Big Market”
New Report Analyzes the Increasingly Critical Role of Intake Management, Market’s Rapid Growth and Evolution…
K10 Esports Embarks on a Revolutionary Journey: From Championships to the TCG World Metaverse
LONDON, Oct 6, 2023 – (ACN Newswire) – In a groundbreaking move that promises to…
Zumo First to Launch Platform Built to Meet the Tech Requirements of the FCA’s New Financial Promotions Regime for Crypto Assets
London/Edinburgh, Oct 6, 2023 – (ACN Newswire) – Zumo, the UK-based digital-asset-as-a-service platform, has announced…
GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers…
SoFi Makes It Possible to Achieve “All Your Ambitions, All In One App”
SoFi’s Latest Campaign, Featuring LA Chargers Quarterback Justin Herbert, Highlights the Unique Ways It Helps…
Data I/O Announces 2023/2024 Fireside Chat Series
Global Perspectives: Data I/O’s CEO Discusses Critical Topics and Emerging Market Trends from Automotive Technologies…
M7 Global Partners Expands North American Reach into Canada; Adds Ferroque Systems to its Partnership Roster
BRAINTREE, Mass.–(BUSINESS WIRE)–M7 Global Partners, a consortium of leading IT consulting firms, today announced the…
ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U.S. FDA for neffy® (epinephrine nasal spray)
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical…
ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U.S. FDA for neffy® (epinephrine nasal spray)
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical…
Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Bon Natural Life Limited Announces Signing MOU for Distributing Jiangwang Spirits in China
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…